SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-136785
Filing Date
2024-05-13
Accepted
2024-05-13 09:14:11
Documents
51
Period of Report
2024-05-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d838124d8k.htm   iXBRL 8-K 79865
2 EX-2.1 d838124dex21.htm EX-2.1 1370914
3 EX-10.1 d838124dex101.htm EX-10.1 51328
4 EX-10.2 d838124dex102.htm EX-10.2 54011
5 EX-10.3 d838124dex103.htm EX-10.3 40364
6 EX-10.4 d838124dex104.htm EX-10.4 295224
7 EX-10.5 d838124dex105.htm EX-10.5 15044
8 EX-10.6 d838124dex106.htm EX-10.6 22882
9 EX-99.1 d838124dex991.htm EX-99.1 32502
10 EX-99.2 d838124dex992.htm EX-99.2 39027
14 GRAPHIC g838124ex99_2p10g1.jpg GRAPHIC 245620
15 GRAPHIC g838124ex99_2p11g1.jpg GRAPHIC 400810
16 GRAPHIC g838124ex99_2p12g1.jpg GRAPHIC 298792
17 GRAPHIC g838124ex99_2p13g1.jpg GRAPHIC 388011
18 GRAPHIC g838124ex99_2p14g1.jpg GRAPHIC 317966
19 GRAPHIC g838124ex99_2p15g1.jpg GRAPHIC 324972
20 GRAPHIC g838124ex99_2p16g1.jpg GRAPHIC 308017
21 GRAPHIC g838124ex99_2p17g1.jpg GRAPHIC 323788
22 GRAPHIC g838124ex99_2p18g1.jpg GRAPHIC 269326
23 GRAPHIC g838124ex99_2p19g1.jpg GRAPHIC 323836
24 GRAPHIC g838124ex99_2p1g1.jpg GRAPHIC 290218
25 GRAPHIC g838124ex99_2p20g1.jpg GRAPHIC 300985
26 GRAPHIC g838124ex99_2p21g1.jpg GRAPHIC 344385
27 GRAPHIC g838124ex99_2p22g1.jpg GRAPHIC 313517
28 GRAPHIC g838124ex99_2p23g1.jpg GRAPHIC 278473
29 GRAPHIC g838124ex99_2p24g1.jpg GRAPHIC 276749
30 GRAPHIC g838124ex99_2p25g1.jpg GRAPHIC 263991
31 GRAPHIC g838124ex99_2p2g1.jpg GRAPHIC 680549
32 GRAPHIC g838124ex99_2p3g1.jpg GRAPHIC 614367
33 GRAPHIC g838124ex99_2p4g1.jpg GRAPHIC 293727
34 GRAPHIC g838124ex99_2p5g1.jpg GRAPHIC 293959
35 GRAPHIC g838124ex99_2p6g1.jpg GRAPHIC 309602
36 GRAPHIC g838124ex99_2p7g1.jpg GRAPHIC 225755
37 GRAPHIC g838124ex99_2p8g1.jpg GRAPHIC 391713
38 GRAPHIC g838124ex99_2p9g1.jpg GRAPHIC 234754
39 GRAPHIC g838124g0511050347457.jpg GRAPHIC 6580
40 GRAPHIC g838124g0511050347754.jpg GRAPHIC 2532
41 GRAPHIC g838124g0512065533548.jpg GRAPHIC 3261
42 GRAPHIC g838124g0512065533771.jpg GRAPHIC 3830
  Complete submission text file 0001193125-24-136785.txt   14131956

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA rphm-20240510.xsd EX-101.SCH 2862
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE rphm-20240510_lab.xml EX-101.LAB 18737
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rphm-20240510_pre.xml EX-101.PRE 11715
54 EXTRACTED XBRL INSTANCE DOCUMENT d838124d8k_htm.xml XML 3772
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 24937137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)